Artofa-ER 11 contains Tofacitinib Extended Release (11 mg) a Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis and other autoimmune conditions. By inhibiting specific enzymes involved in the inflammatory process Tofacitinib helps reduce joint inflammation pain and stiffness improving overall mobility and quality of life for patients. This extended-release formulation allows for convenient once-daily dosing ensuring consistent therapeutic effects throughout the day.






Reviews
There are no reviews yet.